Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR[R43/R44])

The summary for the Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR[R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR[R43/R44]): To encourage new or renewal Small Business Innovation Research (SBIR) grant applications focused on specific product development activities for radiological/nuclear medical countermeasures leading to Investigational New Drug (IND) or Investigational Device Exemption (IDE) submission packages to the U.S. Food and Drug Administration.

Federal Grant Title:	Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR[R43/R44])
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-12-044
Type of Funding:	Grant
CFDA Numbers:	93.855
CFDA Descriptions:	Allergy, Immunology and Transplantation Research
Current Application Deadline:	Jan 07, 2015
Original Application Deadline:	Jan 07, 2015
Posted Date:	December 9th, 2011
Creation Date:	Dec 06, 2011
Archive Date:	Feb 07, 2015
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinica...; • Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clini...; • Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical T...; • NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed); • Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 C...; • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional); • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...; • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...; • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...; • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...